Septicemia From Biliary Tract Infection

Siegman-Igra, Yardena

doi:10.1001/archsurg.1988.01400270106016

Cited by 25 publications

(11 citation statements)

References 12 publications

(2 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The authors, however, did not detail the presence of underlying structural abnormalities. In an Israeli study15 of 70 patients with 76 episodes of bacteraemia, 13/70 (19%) had an underlying malignancy compared with our finding of 18/49 (37%). Patients were classified into three groups: those with cholelithiasis without previous surgery; those with cholangitis after remote or recent cholecystectomy; those with pancreatic or biliary tract tumours.…”

Section: Discussioncontrasting

confidence: 67%

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes

Melzer

Toner

Lacey

et al. 2007

Postgraduate Medical Journal

108

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 67%

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes

Melzer

Toner

Lacey

et al. 2007

Postgraduate Medical Journal

108

View full text Add to dashboard Cite

show abstract

“…Up to 60% of bacteremias in these patients have been reported to be polymicrobial. 30 Neutropenic patients are also susceptible to polymicrobial bacteremia, with polymicrobial bacteremia observed in 8e32% of patients with febrile neutropenia. 4,31 Disruption of the natural mucosal barrier by cytotoxic agents may increase susceptibility to infection, enabling invasion by various bacteria.…”

Section: Discussionmentioning

confidence: 99%

Clinical significance and outcome of polymicrobial Staphylococcus aureus bacteremia

Park¹,

Park²,

Bang³

et al. 2012

Journal of Infection

View full text Add to dashboard Cite

“…In patients with suppurative cholangitis, septicemia occurs in 40-50% of the cases as a result of cholangiovenous reflux. A similar spectrum of bacteria is isolated from blood cultures, E. coli being the organism most commonly isolated [84].…”

Section: Cholangitismentioning

confidence: 99%

Antimicrobial Treatment of Intra-Abdominal Infections

Elsakr

Johnson²,

Younes

et al. 1998

Dig Dis

View full text Add to dashboard Cite

There have been several recent changes that influence the management of intra-abdominal infections. These changes include important developments in antibiotic resistance such as increases in pneumococcal resistance, emergence of multi-drug-resistant enterococcal isolates, and decreasing sensitivity of anaerobes and gram-negative rods. In addition there are new antibiotics such as piperacillin/tazobactam, and new antibiotic dosing regimens such as single daily dosing of aminoglycosides. In this article, we will review the therapeutic approach to intra-abdominal infections with special emphasis on the various forms of peritonitis, cholecystitis, cholangitis, and diverticulitis. Several new concepts about the treatment of enterococcus, the management of bacterial and fungal peritonitis, and the prevention of spontaneous bacterial peritonitis will also be reviewed. Specific recommendations for the management of the different infections including antibiotic doses and costs will be provided. Finally the role of invasive procedures in the management of some of the infections will be explored.

show abstract

Septicemia From Biliary Tract Infection

Cited by 25 publications

References 12 publications

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes

Clinical significance and outcome of polymicrobial Staphylococcus aureus bacteremia

Antimicrobial Treatment of Intra-Abdominal Infections

Contact Info

Product

Resources

About